Abstract
We assessed interfraction positional variation in pancreatic tumors using daily breath‐hold cone‐beam computed tomography at end‐exhalation (EE) with visual feedback (BH‐CBCT). Eleven consecutive patients with pancreatic cancer who underwent BH intensity‐modulated radiation therapy with visual feedback were enrolled. All participating patients stopped oral intake, with the exception of drugs and water, for >3 hr before treatment planning and daily treatment. Each patient was fixed in the supine position on an individualized vacuum pillow. An isotropic margin of 5 mm was added to the clinical target volume to create the planning target volume (PTV). The prescription dose was 42 to 51 Gy in 15 fractions. After correcting initial setup errors based on bony anatomy, the first BH‐CBCT scans were performed before beam delivery in every fraction. BH‐CBCT acquisition was obtained in three or four times breath holds by interrupting the acquisition two or three times, depending on the patient's BH ability. The image acquisition time for a 360° gantry rotation was approximately 90 s, including the interruption time due to BH. The initial setup errors were corrected based on bony structure, and the residual errors in the target position were then recorded. The magnitude of the interruptions variation in target position was assessed for 165 fractions. The systematic and random errors were 1.2 and 1.8 mm, 1.1 and 1.8 mm, and 1.7 and 2.9 mm in the left–right (LR), anterior–posterior (AP), and superior–inferior (SI) directions, respectively. Absolute interfraction variations of >5 mm were observed in 18 fractions (11.0%) from seven patients because of EE‐BH failure. In conclusion, target matching is required to correct interfraction variation even with visual feedback, especially to ensure safe delivery of escalated doses to patients with pancreatic cancer.PACS number: 87.57.Q‐, 87.57.‐s, 87.55.Qr
Highlights
The National Cancer Institute reported that an estimated 46,420 new cases and 39,590 deaths from pancreatic cancer occurred in 2014 in the United States.[1]
109 Nakamura et al.: Interfraction positional variation in pancreatic tumors using breath hold (BH)-cone-beam CT (CBCT) 109 most patients present with locally advanced, unresectable, or metastatic disease at diagnosis.[2] radiation therapy has been an important option for these patients, radiation therapy for pancreatic cancer is highly toxic in some cases, partly because of the high dose to the surrounding organs at risk (OARs).(3,4) Severe gastrointestinal (GI) toxicity is generally related to high-dose volumes in the stomach and bowels.[3,4]
One method by which to reduce the high dose to such organs is management of respiratory motion.[5,6] Several researchers have reported that pancreatic tumor motion due to breathing exceeded 10 mm using cine magnetic resonance images, four-dimensional computed tomography (CT), electromagnetic transponders, and cone-beam CT (CBCT).(7-14) Without respiratory management, a large planning target volume (PTV) is needed to cover such internal motion, resulting in inclusion of a large volume of OARs
Summary
One method by which to reduce the high dose to such organs is management of respiratory motion.[5,6] Several researchers have reported that pancreatic tumor motion due to breathing exceeded 10 mm using cine magnetic resonance images, four-dimensional computed tomography (CT), electromagnetic transponders, and cone-beam CT (CBCT).(7-14) Without respiratory management, a large planning target volume (PTV) is needed to cover such internal motion, resulting in inclusion of a large volume of OARs. To achieve dose escalation in patients with locally advanced unresectable pancreatic cancer, we applied hypofractionated intensity-modulated radiotherapy (IMRT) combined with breath hold (BH) at end-exhalation (EE) using visual feedback. There have been no reports of interfraction positional variations in pancreatic tumors using BH-CBCT at EE
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have